Literature DB >> 4058672

Ceroid-lipofuscinosis (Batten's disease): pathogenesis of blindness in the ovine model.

I G Mayhew, R D Jolly, B T Pickett, P M Slack.   

Abstract

Blindness is a feature of the group of storage diseases of children known as the ceroid-lipofuscinoses. Sequential studies in the ovine model, which most resembles the juvenile form of human disease, showed clearly that blindness had two components, a central and a peripheral. Whereas the central component, attributable to neuronal death and atrophy of the cerebral cortex, was responsible for early loss of vision, retinal atrophy was also extremely advanced in terminal stages of the disease. The primary retinal change was one of dystrophy of photoreceptor outer segments which preceded degeneration and necrosis of the photoreceptors cells themselves. Electroretinography showed that there was a progressive loss of a- and b-waves during the course of the disease, but this was preceded by a diminished c-wave which was eventually replaced by a negative potential. However, the pigment epithelium remained functionally (azide responsive) and ultrastructurally intact throughout the study. Loss of brain weight with selective cerebral atrophy also correlated with abnormal behaviour and facial manoeuvres that were interpreted as partial seizures that did not become generalized.

Entities:  

Mesh:

Year:  1985        PMID: 4058672     DOI: 10.1111/j.1365-2990.1985.tb00025.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  14 in total

1.  The sequence of the major protein stored in ovine ceroid lipofuscinosis is identical with that of the dicyclohexylcarbodiimide-reactive proteolipid of mitochondrial ATP synthase.

Authors:  I M Fearnley; J E Walker; R D Martinus; R D Jolly; K B Kirkland; G J Shaw; D N Palmer
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

2.  Neurovisceral ceroid-lipofuscinosis in blind Devon cattle.

Authors:  P A Harper; K H Walker; P J Healy; W J Hartley; A J Gibson; J S Smith
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 3.  Ceroid, lipofuscin and the ceroid-lipofuscinoses (Batten disease).

Authors:  R D Jolly; R R Dalefield; D N Palmer
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

4.  Neuronal ceroid lipofuscinosis in the Polish Owczarek Nizinny (PON) dog. A retinal study.

Authors:  A Wrigstad; S E Nilsson; R Dubielzig; K Narfström
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

5.  Lectin histochemistry of mammalian endothelium.

Authors:  J Alroy; V Goyal; E Skutelsky
Journal:  Histochemistry       Date:  1987

6.  Enhanced expression of manganese-dependent superoxide dismutase in human and sheep CLN6 tissues.

Authors:  Claudia Heine; Jaana Tyynelä; Jonathan D Cooper; David N Palmer; Milan Elleder; Alfried Kohlschütter; Thomas Braulke
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

7.  Location and connectivity determine GABAergic interneuron survival in the brains of South Hampshire sheep with CLN6 neuronal ceroid lipofuscinosis.

Authors:  Manfred J Oswald; David N Palmer; Graham W Kay; Karen J Barwell; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2008-06-25       Impact factor: 5.996

8.  Ovine ceroid-lipofuscinosis is a proteolipid proteinosis.

Authors:  R D Jolly; R D Martinus; A Shimada; I M Fearnley; D N Palmer
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

9.  Quantitative autofluorescence in the ovine and canine ocular fundus in ceroid-lipofuscinosis (Batten's disease).

Authors:  D Armstrong; G Gum; A Webb; R Jolly
Journal:  Vet Res Commun       Date:  1988       Impact factor: 2.459

10.  Increased zinc and manganese in parallel with neurodegeneration, synaptic protein changes and activation of Akt/GSK3 signaling in ovine CLN6 neuronal ceroid lipofuscinosis.

Authors:  Katja M Kanninen; Alexandra Grubman; Jodi Meyerowitz; Clare Duncan; Jiang-Li Tan; Sarah J Parker; Peter J Crouch; Brett M Paterson; James L Hickey; Paul S Donnelly; Irene Volitakis; Imke Tammen; David N Palmer; Anthony R White
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.